USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/9941
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNeelankavil Joel, George
dc.date.accessioned2020-05-27T15:26:15Z
dc.date.available2020-05-27T15:26:15Z
dc.date.issued2018
dc.identifier.citationNEELANKAVIL, Joel George. Evolving role of nuclear medicine modalities in the evaluation of renal diseases. In: The Moldovan Medical Journal. 2018, vol. 61, RMI Congress Issue, p. 96. ISSN 2537-6381.
dc.identifier.issn2537-6373
dc.identifier.issn2537-6381 (Online)
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2018/05/The-Moldovan-Medical-Journal-vol-61-mai.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/9941
dc.descriptionDepartment of Radiology and Imaging, Nicolae Testemitanu State University of Medicine and Pharmacy Chisinau, the Republic of Moldova, The IVth Congress of Radiology and Medical Imaging of the Republic of Moldova with international participation, Chisinau, May 31 – June 2, 2018en_US
dc.description.abstractBackground: Nuclear medicine in renal diseases is becoming one of the most important modalities of investigation. Material and methods: The study involved a search of the Pubmed Central database with the keywords renal scintigraphy, renal diseases, nuclear medicine, kidney function. The retrieved articles were studied and nuclear medicine techniques used for evaluation of kidney diseases were summarized. Results: The search revealed 9899 articles, which were subsequently filtered according to their relevance. The results show several groups of radiopharmaceuticals used for evaluation of renal function and renal abnormalities. Tubular secretion agents such as Tc-99m MAG3 are most commonly used for evaluating renal function, obtaining renograms and a variety of parameters reflecting differential renal function such as time to peak activity, relative renal uptake ratios at 2 to 3 minutes, half time excretion, differential cortical excretion at 15 minutes, 20-min to peak count ratio, etc. Glomerular filtration agents such as Tc-99m DTPA and 125-I-labeled sodium lothalamate (Glofil) are commonly used for evaluation of glomerular filtration rate. Renal cortical agents such as Tc-99m DMSA and Tc-99m glucoheptonate are used for visualization of renal parenchyma due to their ability to bind for a sufficiently long period to the renal tubules, allowing their visualization. Positron emission tomography agents such as 2-deoxy-2-[fluorine-18]fluoro- D-glucose (18F-FDG) are commonly used for evaluation of patients with primary renal malignancies or metastatic renal lesions. A variety of other radiopharmaceuticals are also under development or used for research purposes. Conclusions: Nuclear medicine is increasingly being used in patients with various renal abnormalities and its area of applications is expanding.en_US
dc.language.isoenen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldovaen_US
dc.relation.ispartofThe Moldovan Medical Journal: The IVth Congress of Radiology and Medical Imaging of the Republic of Moldova with international participation, Chisinau, May 31 – June 2, 2018
dc.subjectrenal scintigraphyen_US
dc.subjecttubular secretion agentsen_US
dc.subjectglomerular filtration agentsen_US
dc.subjectrenal cortical agentsen_US
dc.titleEvolving role of nuclear medicine modalities in the evaluation of renal diseasesen_US
dc.typeOtheren_US
Appears in Collections:The Moldovan Medical Journal, Vol. 61, May 2018 RMI Congress Issue

Files in This Item:
File Description SizeFormat 
Evolving_role_of_nuclear_medicine_modalities_in_the_evaluation_of_renal_diseases.pdf72.82 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback